Tenaya Therapeutics Publishes Preclinical Data in Circulatio

SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies

Related Keywords

United States , California , American , Faraz Ali , Wendy Ryan , Julie Seidel , Deepak Srivastava , Tim Hoey , Corporate Communications , Securities Exchange , Gladstone Institute Of Cardiovascular Disease , Nasdaq , Exchange Commission , Tenaya Therapeutics Inc , California Institute For Regenerative Medicine , Tenaya Cellular Reprogramming Research , American Heart Association , Cardiac Function , Postischemic Rats Using , Single Novel Adeno Associated Virus , Chief Scientific Officer , Chief Executive , California Institute , Regenerative Medicine , Gladstone Institute , Cardiovascular Disease , Tenaya Board , Tenaya Scientific Advisory , Prior Tenaya , Gene Therapy , Cellular Regeneration , Precision Medicine , Securities Act , Securities Exchange Act , Region ,